From L-R: AstraZeneca CEO Pascal Soriot, CFO Aradhana Sarin and Alexion CEO Marc Dunoyer presenting Q4 results (Reynald Castañeda for Endpoints News)

Up­dat­ed: ‘Ruth­less’ pipeline pri­or­i­ti­za­tion, obe­si­ty and Chi­na: Three take­aways from As­traZeneca’s Q4 

LON­DON — As­traZeneca on Thurs­day morn­ing teased its vi­sion on how it could po­ten­tial­ly en­ter the obe­si­ty mar­ket, as well as its views on fur­ther …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.